Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-2010 | 06-2010 | 04-2010 | 03-2010 | 01-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 277 | -6,796 | 259 | -5,380 | 4,261 |
| Depreciation Amortization | 389 | 231 | 131 | 114 | 811 |
| Income taxes - deferred | 198 | N/A | 180 | N/A | -14 |
| Accounts receivable | -621 | N/A | -365 | N/A | -1,827 |
| Accounts payable and accrued liabilities | -942 | 343 | -159 | 559 | -170 |
| Other Working Capital | -2,085 | -257 | -922 | -31 | -5,919 |
| Other Operating Activity | 1,821 | -909 | 858 | 813 | 2,826 |
| Operating Cash Flow | $-963 | $-7,388 | $-18 | $-3,925 | $-32 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -672 | -362 | -388 | -312 | -1,991 |
| Purchase Of Investment | N/A | -45,218 | N/A | -3,073 | N/A |
| Purchase Sale Intangibles | N/A | -45 | N/A | -28 | N/A |
| Other Investing Activity | 0 | -51 | 0 | -34 | 0 |
| Investing Cash Flow | $-672 | $-45,631 | $-388 | $-3,419 | $-1,991 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 892 | N/A | 335 | N/A | 1,618 |
| Debt Issued | 6,012 | N/A | 600 | N/A | 800 |
| Debt Repayment | -5,195 | -15 | -99 | -5 | -395 |
| Common Stock Issued | N/A | 293 | N/A | N/A | N/A |
| Financing Cash Flow | $1,709 | $278 | $836 | $-5 | $2,023 |
| Beginning Cash Position | 0 | 58,072 | N/A | 58,072 | N/A |
| End Cash Position | 74 | 5,331 | 430 | 50,723 | N/A |
| Net Cash Flow | $74 | $-52,741 | $430 | $-7,349 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -963 | -7,388 | -18 | -3,925 | -32 |
| Capital Expenditure | -672 | -362 | -388 | -312 | -1,991 |
| Free Cash Flow | -1,635 | -7,750 | -406 | -4,237 | -2,023 |